fda and compound semaglutide Novo asks to prevent compounders from making GLP-1 knockoffs FDA issues warning about some

Adjacent Agents and Real-World Stacking Behavior Patients using BPC-157 or TB-500 frequently engage in broader self-directed health or recovery strategies, often combining multiple agents with overlapping physiologic effects

Senator Tommy Tuberville had also written Kennedy this summer asking for enforcement discretion on many substances including a bunch of unproven wellness peptides

To qualify for exemptions from the Federal Food, Drug and Cosmetic (FD&C) Act, compounded drugs must meet specific conditions, including: No copies of commercially available drugs (drugs that aren't in shortage) No identical or nearly identical copies of FDA-approved drugs unless in shortage Always consult with your healthcare provider first to determine if a compounded drug is appropriate for you

Osmotic diarrhea may result and is of particular concern in infants